Benzinga | Aug 14, 2020 07:39AM EDT

Sonnet BioTherapeutics Q2 EPS $(1.05) Down From $(0.26) YoY

Sonnet BioTherapeutics (NASDAQ:SONN) reported quarterly losses of $(1.05) per share. This is a 303.85 percent decrease over losses of $(0.26) per share from the same period last year.